SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (462)3/14/1997 9:35:00 PM
From: scaram(o)uche   of 6136
 
meanwhile, we have yet to hear from Japan Tobacco.....

and, in the spirit of musical analysts.....

* PaineWebber analyst Alise Wang has restarted coverage of
AGOURON PHARMACEUTICALS INC. with a rating of buy, a source at
the brokerage said on Friday.

* Morgan Stanley analyst Doug Lind, who recently joined the firm
from PaineWebber, initiated coverage of AGOURON PHARMACEUTICALS
INC. as strong buy.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News